ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

KNOS Kainos Group Plc

745.50
4.50 (0.61%)
Share Name Share Symbol Market Type Share ISIN Share Description
Kainos Group Plc LSE:KNOS London Ordinary Share GB00BZ0D6727 ORD 0.5P
  Price Change % Change Share Price Shares Traded Last Trade
  4.50 0.61% 745.50 1,635,456 16:35:19
Bid Price Offer Price High Price Low Price Open Price
741.00 743.50 751.50 740.50 741.00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Prepackaged Software 367.25M 35.56M 0.2910 25.46 905.46M
Last Trade Time Trade Type Trade Size Trade Price Currency
16:49:29 O 2 745.00 GBX

Kainos (KNOS) Latest News (3)

Kainos (KNOS) Discussions and Chat

Kainos Forums and Chat

Date Time Title Posts
05/6/202511:18Kainos Group - Software Solutions Superstars2,800
21/6/201711:28Kainos Group plc356
01/8/201512:24Kainos1

Add a New Thread

Kainos (KNOS) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type

Kainos (KNOS) Top Chat Posts

Top Posts
Posted at 22/6/2025 09:20 by Kainos Daily Update
Kainos Group Plc is listed in the Prepackaged Software sector of the London Stock Exchange with ticker KNOS. The last closing price for Kainos was 741p.
Kainos currently has 122,194,357 shares in issue. The market capitalisation of Kainos is £905,460,185.
Kainos has a price to earnings ratio (PE ratio) of 25.46.
This morning KNOS shares opened at 741p
Posted at 19/5/2025 07:26 by mrscruff
KNOS (FY ending Mar 2025):
+9% total revenue (to £397.1m)
+34% SaaS growth
+29% Workday Products segment

Adjusted pre-tax profit up +3% to £75.2m
Statutory PBT down -5%

Margins under slight pressure as they scale Workday & SaaS. But this is because KNOS is in a strong growth phase and also restructuring for the long run 💪
Posted at 16/4/2025 11:03 by 74tom
Having run the numbers, over the last 20 half year periods the average EV/EBITDA for KNOS has been 22.2x, currently it's ~10.6x. Make of that what you will...
Posted at 15/4/2025 12:37 by ali47fish
74tom- the gist of you post is knos results are good but isn't the valuation high
Posted at 15/4/2025 09:16 by 74tom
I think the two declared notified short sellers have been caught out by yesterday's positive update. GLG in particular seem to have got overly aggressive post the November interims and increased their short from 0.85% to 1.29%, indeed it was as high as 1.7% in Jan.

It looks like they went above the notifiable threshold way back in May 2023, so that portion of their short is likely from the £12-14 level. Back then KNOS was valued at ~22x EV/Adjusted PBT, so I can certainly see the fundamental short case at those levels if they thought a slowdown was coming.

Now though? Based on yesterday's numbers and assuming £150m cash at year end, it's just over 10x EV/Adjusted PBT. If growth returns in any meaningful way then that valuation is way too cheap.

In many ways this reminds me of KWS; a fallen star that has temporarily gone ex growth but is still churning out huge FCF. Vulture short sellers have pushed it too far down and it's now fundamentally undervalued. Consequently, I think KNOS will be near the top of the PE wishlist and a bit at a >100% premium seems entirely possible.

Regardless, I think a re-rate back towards £10 is likely by the final results, especially as shares got to £12.80 last May...
Posted at 14/4/2025 15:29 by martinmc123
wealthoracle.co.uk/detailed-result-full/KNOS/1357
Posted at 31/10/2024 08:15 by volsung
Used to park outside knos offices when I was going to classes in the Crescent Arts Centre
Posted at 30/10/2024 18:34 by shared24
I haven't come across any explicitly negative sentiment about Kainos in the press or online. Most analyses I've seen have consistently recommended a 'HOLD' rating. Given the recent decline in the share price, and with the increased NHS spending outlined in the budget, there's a reasonable expectation for a recovery. I believe a fair value target near 9-10 is achievable. The next trading update will help as well.
Posted at 02/9/2024 09:48 by 74tom
No they didn't, someone sold 250k and someone bought 250k, i.e. an exchange. If someone had bought 500k vs the current volume of 776k then shares wouldn't be down 15%!

Here is what almost certainly happened;

An institutional shareholder didn't like the tone of the TU, they tell the market makers / broker that they want to sell 250k+ shares. The market makers / brokers get on their phones and try to find a buyer. A buyer is located and says they will pay £9.50. The deal is agreed and then published on the order book. In the meantime the share price has been walked down to match this activity.

Regarding the valuation, any company on 22x earnings which misses on revenue is going to come under pressure, as there is only so far that gross / operating margins can stretch before a top line downgrade results in an EPS miss.

I'd say 15-17x current year EPS forecast of 48.5p is more than fair if their competitive environment has become more difficult, as either pricing has had to be lowered to retain customers or they've lost share to competitors. So 720-820p would be my marker for this to get interesting.
Posted at 02/9/2024 09:16 by johnsoho
I think there has been a large over-reaction to this trading statement and I think, expect, a recovery to the share price over the next week or so. The workday products division appear to be performing very well.

I’ve pasted a copy of the trading update below.

For the year ending 31 March 2025, the Board expects to deliver adjusted PBT in line with current market consensus forecasts, but due to the tougher trading environment in services in the financial year to date, expects only a small increase in overall revenues, which will be below current market consensus forecasts.*

Given the current macro-economic environment, the Board continues to believe that we are maintaining the appropriate balance between profitability, investment for future growth and international expansion.

Financial year to date divisional performance and outlook

· In Digital Services, there has been sustained demand from our Public Sector clients offset by some delays around project mobilisation as result of the short-term impact of the UK General Election. Healthcare revenues continue to grow while the previously announced weakness in demand within our commercial clients continues as project related expenditure decision making is delayed. Overall, there has been a subdued start to the year but expect to see revenue growth over the remainder of this year.

· In Workday Services, we remain a leading partner in the Workday consulting sector. Our win rate has remained robust, but contract wins and values have been lower than in previous periods, and there has been more aggressive pricing amongst partners. Cumulatively, this has impacted our divisional performance in the short-term although we expect a return to growth in the second half of the year.

· Our Workday Products division continues to deliver very strong growth. Our enhanced strategic partnership with Workday to co-sell our products (announced on 25 July 2024) has meaningfully increased our customer reach, increased our ARR target from £100m to £200m and will accelerate the recurring software proportion of group revenue beyond the previous 15% in FY2024. In the 5 weeks since announcing the partnership, we have made excellent progress with sales enablement and expect the upcoming Workday Rising event to be a positive catalyst.

We look forward with confidence to the remainder of the year, supported by a healthy pipeline, a strong balance sheet and significant contracted backlog. Looking further ahead we are well positioned in our core markets which offer substantial growth opportunities in all our divisions.

Our performance continues to be underpinned by our long-term customer relationships, and the calibre of our people, who continue to excel in delivering high-impact solutions for our customers. As always, we are grateful for the ongoing trust of our customers and the efforts of our colleagues across the world.

The announcement of our results for the six months ending 30 September 2024 will be made on 11 November 2024.
Posted at 05/1/2022 14:03 by johnsoho
Knos share price seams to be bouncing about like a yo-yo, anyone any idea why ?
Kainos share price data is direct from the London Stock Exchange

Kainos Frequently Asked Questions (FAQ)

What is the current Kainos share price?
The current share price of Kainos is 745.50p
How many Kainos shares are in issue?
Kainos has 122,194,357 shares in issue
What is the market cap of Kainos?
The market capitalisation of Kainos is GBP 905.46M
What is the 1 year trading range for Kainos share price?
Kainos has traded in the range of 582.50p to 1,142.00p during the past year
What is the PE ratio of Kainos?
The price to earnings ratio of Kainos is 25.46
What is the cash to sales ratio of Kainos?
The cash to sales ratio of Kainos is 2.47
What is the reporting currency for Kainos?
Kainos reports financial results in GBP
What is the latest annual turnover for Kainos?
The latest annual turnover of Kainos is GBP 367.25M
What is the latest annual profit for Kainos?
The latest annual profit of Kainos is GBP 35.56M
What is the registered address of Kainos?
The registered address for Kainos is 21 FARRINGDON ROAD, 2ND FLOOR, LONDON, EC1M 3HA
What is the Kainos website address?
The website address for Kainos is www.kainos.com
Which industry sector does Kainos operate in?
Kainos operates in the PREPACKAGED SOFTWARE sector

Your Recent History

Delayed Upgrade Clock